Update regarding Better Transaction
November 23, 2022 16:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 23, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company") is hereby providing...
Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
November 17, 2022 08:17 ET
|
InterCure Ltd.
TORONTO and HERZILA, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”), a leading Canadian licensed producer of cannabis, and Canndoc Ltd....
CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
November 15, 2022 11:18 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, by InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR),...
InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
November 15, 2022 09:03 ET
|
InterCure Ltd.
Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of $155 million Adjusted EBITDA1 run rate of $36 million Achieved Run Rate Net Profit...
InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY
November 11, 2022 08:32 ET
|
InterCure Ltd.
Estimated revenue reaches CAD$39 million1 (a record of over NIS 100 million): Eleventh consecutive quarter of profitable growth with revenue growth expected to continue in Q4 2022 NEW YORK and...
Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders
September 16, 2022 16:30 ET
|
InterCure Ltd.
HERZLIYA, Israel, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Intercure Ltd. (the “Company”) announces today the results of the Annual and Special General Meeting of shareholders of the Company, held on...
InterCure Reports Record Breaking Second Quarter Financial Results
August 15, 2022 09:15 ET
|
InterCure Ltd.
Record revenue of over $37 millioni in the second quarter of 2022 Representing an annual run rate of $150 million Adjusted EBITDAii for Q2 increased 90% YoY to $9 million Net income of $6...
InterCure to Release its Q2 2022 Results and Hold a Conference Call
August 11, 2022 10:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth
July 21, 2022 09:00 ET
|
InterCure Ltd.
Estimated revenue reaches CAD$36 million 1(a record NIS 95 million) Anticipates continued increases in EBITDA Revenue growth expected to continue in Q3 and throughout 2022 NEW...
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
June 21, 2022 08:40 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, June 21, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the successful...